RESUMEN
The routine diagnosis of hepatitis C virus (HCV) infection is based on the detection of anti-HCV antibodies by two main methods (enzyme immunoassay [EIA] and chemiluminescence immunoassay [CIA]) but false-positives are a problem. We investigated three anti-HCV tests: two CIAs (Cobas e 601 and Architect i2000SR); and one EIA (Ortho HCV 3.0). Two other anti-HCV tests were also performed as supplementary and confirmatory tests, respectively: a recombinant strip immunoblot assay (RIBA HCV 3.0 SIA) and a reverse transcriptase polymerase chain reaction-based assay for HCV-RNA. After discriminating the false-positive results, the true anti-HCV seropositivity rate in 7156 serum samples was 0.91%. The seropositivity and false-positive rates for the Cobas e 601, Architect i2000SR and Ortho HCV 3.0 anti-HCV tests were 1.9% and 0.99%, 1.2% and 0.29%, and 0.87% and 0.01%, respectively. The mean level of HCV-RNA was 3399 x 10(3) IU/ml. Critical levels for false-positivity for HCV-RNA were a cut-off index of 200 for Cobas e 601, a signal/cut-off (S/CO) of 5 for Architect i2000SR and an S/CO of 1.2 for Ortho HCV 3.0. Positive and negative results for the RIBA HCV 3.0 SIA assay all accorded with the HCV-RNA assay, except for 23 (17%) 'indeterminate' results, all of which were negative with the HCV-RNA assay. In conclusion, to eliminate doubts related to false-positive findings in the initial HCV screening tests, additional confirmatory HCV-RNA assay should be performed.
Asunto(s)
Ensayo de Inmunoadsorción Enzimática/métodos , Hepacivirus/patogenicidad , Anticuerpos contra la Hepatitis C/inmunología , Hepatitis C/diagnóstico , Hepatitis C/virología , Técnicas para Inmunoenzimas/métodos , Mediciones Luminiscentes/métodos , Adolescente , Adulto , Anciano , Niño , Preescolar , Femenino , Hepacivirus/inmunología , Hepatitis C/sangre , Humanos , Lactante , Recién Nacido , Masculino , Persona de Mediana Edad , Juego de Reactivos para Diagnóstico , Turquía , Adulto JovenRESUMEN
OBJECTIVE: Sibutramine is an effective appetite suppresser agent, but treatment is often complicated with side effects, including palpitations and hypertension. In this study, we aimed to assess the effect of low-dose cardio-selective beta blocker combination with sibutramine treatment. METHODS: In total, 57 obese subjects were enrolled in the study and separated into two groups in order to receive sibutramine 10 mg/day plus placebo (group P) or sibutramine 10 mg/day plus metoprolol 25 mg/day (group M). Patients were evaluated in the beginning and at the end of the third month with anthropometric measurements, biochemical analysis, peripheral insulin resistance, and ambulatory 24 h blood pressure monitoring. Side effects were evaluated with a visual analog scale. RESULTS: During the study period, the drop-out rate was significantly higher in group P compared with group M (55 and 21%, respectively, P=0.014). Palpitations and headache were prominent symptoms in group P. Diastolic blood pressure (78.6+/-11.6 and 70.6+/-4.8 mmHg, respectively, P=0.013) and mean heart rate (84.3+/-6.1 and 75.8+/-8.4 beats/min, respectively, P=0.003) were significantly higher in group P compared with group M at the end of the third month. Weight loss was similar between the two groups (100.9+/-11.5 to 91.8+/-12.8 kg for group P, P<0.0001 and 97.9+/-13.2 to 88.9+/-13.8 kg for group M, P<0.0001). We did not find any deleterious effect of metoprolol on metabolic parameters. CONCLUSION: Addition of low-dose metoprolol to sibutramine therapy increased patient compliance to the treatment, and decreased the frequency and severity of side effects including hypertension and palpitations, without decreasing the drug efficacy or causing significant deleterious changes in metabolic parameters.
Asunto(s)
Antagonistas Adrenérgicos beta/administración & dosificación , Depresores del Apetito/administración & dosificación , Ciclobutanos/administración & dosificación , Metoprolol/administración & dosificación , Obesidad/tratamiento farmacológico , Adulto , Antropometría , Depresores del Apetito/efectos adversos , Arritmias Cardíacas/inducido químicamente , Arritmias Cardíacas/prevención & control , Ciclobutanos/efectos adversos , Esquema de Medicación , Quimioterapia Combinada , Femenino , Humanos , Hipertensión/inducido químicamente , Hipertensión/prevención & control , Masculino , Persona de Mediana Edad , Cooperación del Paciente , Pérdida de Peso/efectos de los fármacosRESUMEN
We present a 65-year-old man who had a significant arteriovenous fistula between the right arteria profunda femoralis and vena profunda femoralis. He had evidence of chronic venous insufficiency and chronic leg ulcers on his right leg, and he had clinical findings of congestive heart failure. An arteriovenous fistula was responsible for all of clinical situation that had been caused by a shotgun wound 15 years ago. Using ultrasonography, after palpating a marked thrill and mass during physical examination, established the diagnosis of arteriovenous fistula. Angiography was performed both to delineate the suspected vascular anatomy and to show the coronary arteries. The patient was operated on and no complication was experienced during or after the procedure. Dramatic improvement was seen in the clinical picture just after surgery, and heart size markedly reduced both on chest X-ray and echocardiographic examination.
Asunto(s)
Fístula Arteriovenosa/complicaciones , Arteria Femoral/lesiones , Vena Femoral/lesiones , Insuficiencia Cardíaca/etiología , Traumatismos de la Pierna/complicaciones , Úlcera Varicosa/etiología , Insuficiencia Venosa/etiología , Heridas por Arma de Fuego/complicaciones , Anciano , Fístula Arteriovenosa/diagnóstico , Fístula Arteriovenosa/cirugía , Diagnóstico por Imagen , Arteria Femoral/cirugía , Vena Femoral/cirugía , Insuficiencia Cardíaca/diagnóstico , Humanos , Masculino , Úlcera Varicosa/diagnóstico , Insuficiencia Venosa/diagnósticoRESUMEN
Patent ductus arteriozus (PDA) is the most common type of extracardiac shunt and it usually closes within 2 or 3 days of birth, but it may remain patent for one's lifetime. In this paper, we report a 65-year-old woman with PDA associated with a right coronary arising anomaly. To our knowledge, the anomalous origin of the right coronary artery associated with PDA has not been published to date. In this case report, we used only the standard Judkins type of a left coronary catheter for cannulation of both left and right coronary arteries and as well as PDA.
Asunto(s)
Anomalías de los Vasos Coronarios/complicaciones , Conducto Arterioso Permeable/complicaciones , Anciano , Cateterismo Cardíaco , Anomalías de los Vasos Coronarios/diagnóstico , Anomalías de los Vasos Coronarios/cirugía , Conducto Arterioso Permeable/diagnóstico , Conducto Arterioso Permeable/cirugía , Femenino , HumanosRESUMEN
AIM: The aim of this study was to investigate iron status and its relationships with lipid peroxidation in patients with acute myocardial infarction (MI). METHODS: The study included 30 male patients aged between 32 and 73 years (mean 55 +/- 6) with acute MI. We measured the levels of plasma iron, transferrin (TF), ferritin (FER), ceruloplasmin (CER), cardiac enzymes, and erythrocyte malondialdehyde (e-MDA) in patients with acute MI on the admission and 1st, 3rd, 5th, 7th, 15th, 45th post MI day and investigated the variations of these parameters in acute MI. RESULTS: The e-MDA level started to increase on the admission day and showed a peak value on the post MI 1st day (88 +/- 23 and 98 +/- 26 nmol/g Hb, respectively). Afterwards, the e-MDA level minimally changed until post Ml 45th day, which showed a minimum level (57 +/- 13 nmol/g Hb) (p < 0.05). In addition, the iron concentration of serum reached its maximum level on the 1st post Ml day (99 +/- 30 mg/dl, p < 0.05) and relatively decreased after the 3rd day. Courses of MDA and iron levels were similar. The FER level started to increase from the admission day of the patients (230 +/- 375 mg/dl), showed a mean peak value on the 3rd day (296 +/- 568 mg/dl) and decreased to a minimum level on the 45th day (121 +/- 85 mg/dl) (p < 0.05). Contrarily, the TF level started to decrease on the 1st day (221 +/- 44 mg/dl), decreased minimum level on the 3rd day (211 +/- 37 mg/dl) and continued approximately the same level until the 45th day (244 +/- 45 mg/dl) (p < 0.05). The CER level started to increase from the first day of admission of the patients (43 +/- 12 mg/dl), reached a maximum level on the 7th day (59 +/- 12 mg/dl) and similar levels were observed until the 15th day. On the 45th day, the CER level was higher than on the first day (52 +/- 13 mg/dl) (p < 0.05). CONCLUSION: There was an association of higher iron status with increased lipid peroxidation in patients with myocardial infarction.
Asunto(s)
Hierro/sangre , Peroxidación de Lípido , Infarto del Miocardio/sangre , Adulto , Anciano , Análisis de Varianza , Ceruloplasmina/metabolismo , Ferritinas/sangre , Humanos , Masculino , Malondialdehído/sangre , Persona de Mediana Edad , Estudios Prospectivos , Estadísticas no Paramétricas , Transferrina/metabolismoRESUMEN
BACKGROUND: Elevated C-reactive protein (CRP) has been found to correlate with higher risk for cardiac events in patients with acute myocardial infarction (AMI). It has been suggested that CRP may be involved in initiation process of coagulation; however, the role of CRP level in the formation of left ventricular (LV) thrombus has not been studied. HYPOTHESIS: This study investigated whether CRP is a risk factor for LV thrombus in patients with AMI. METHODS: Clinical, echocardiographic, and biochemical data were analyzed in 141 consecutive patients (aged 57 +/- 13 years; 33 women) with first anterior AMI. Two-dimensional and Doppler echocardiographic examinations were performed on Days 1, 3, 7, 15, and 30. Blood samples were obtained every day during hospitalization. Serum CRP concentrations were measured by an ultrasensitive immunonephelometry method. RESULTS: Left ventricular thrombus was detected in 33 (23.4%) patients. Univariate analysis showed that patients with LV thrombus had a higher peak creatine kinase (CK) level (2,879 +/- 742 vs. 1,693 +/- 1,210 I/U, p = 0.001), higher peak CRP level (14.9 +/- 7.1 vs. 9.2 +/- 6.8 mg/dl, p = 0.001), higher wall motion score index (1.8 +/- 0.2 vs. 1.5 +/- 0.3, p = 0.002), higher apical wall motion score index (2.35 +/- 0.72 vs. 2.07 +/- 0.70, p = 0.001), larger end-diastolic volume (145.2 +/- 43.7 vs. 116.5 +/- 44.2 ml, p = 0.002), larger end-systolic volume (85.4 +/- 37.2 vs. 62.9 +/- 31.6 ml, p = 0.003), and lower ejection fraction (42.1 +/- 12 vs. 47.3 +/- 13, p = 0.04). In multivariate analyses, only peak CK level (p = 0.0001), LV apical wall motion score index (p = 0.001), and CRP levels (p = 0.001) were independent predictors of LV thrombus formation. CONCLUSIONS: These results suggest that CRP is a risk factor for LV thrombus in patients with AMI.
Asunto(s)
Proteína C-Reactiva , Infarto del Miocardio/complicaciones , Trombosis/diagnóstico , Trombosis/etiología , Disfunción Ventricular Izquierda/complicaciones , Adulto , Anciano , Proteína C-Reactiva/metabolismo , Creatina Quinasa/sangre , Femenino , Ventrículos Cardíacos , Humanos , Lípidos/sangre , Masculino , Persona de Mediana Edad , Infarto del Miocardio/sangre , Factores de Riesgo , Volumen Sistólico/fisiología , Trombosis/sangre , Disfunción Ventricular Izquierda/sangreRESUMEN
OBJECTIVE: To assess cardiac function in patients with hypogonadotropic hypogonadism. STUDY DESIGN: We studied heart structure and left ventricular systolic and diastolic function by echocardiography in 38 patients with hypogonadotropic hypogonadism (34 men and 4 women, mean age 24 +/- 4 years) and in 30 healthy subjects (25 men and 5 women, mean age 22 +/- 3 years). Left ventricular end-diastolic diameter, end-systolic diameter, left ventricular septal wall thickness, posterior wall thickness and ejection fractions were measured by M-mode echocardiography. Parameters of mitral flow were measured by pulsed wave Doppler echocardiography. RESULTS: Between patients with and without hypogonadotropic hypogonadism, there were no significant differences in echocardiographic measurements. CONCLUSION: Cardiac function is normal in patients with hypogonadotropic hypogonadism.
Asunto(s)
Ecocardiografía Doppler de Pulso , Hipogonadismo/patología , Hipogonadismo/fisiopatología , Función Ventricular Izquierda , Adulto , Presión Sanguínea , Estudios de Casos y Controles , Femenino , Frecuencia Cardíaca , Humanos , Hipogonadismo/diagnóstico por imagen , Masculino , Valores de ReferenciaRESUMEN
The relation between left ventricular filling pattern and the occurrence of paroxysmal atrial fibrillation was evaluated using Doppler echocardiography in a prospective series of 157 patients with acute myocardial infarction. Paroxysmal atrial fibrillation after acute myocardial infarction was often associated with a higher restrictive filling pattern.
Asunto(s)
Fibrilación Atrial/etiología , Infarto del Miocardio/complicaciones , Disfunción Ventricular Izquierda/etiología , Anciano , Fibrilación Atrial/fisiopatología , Velocidad del Flujo Sanguíneo/fisiología , Estudios de Casos y Controles , Circulación Coronaria/fisiología , Diástole/fisiología , Ecocardiografía Doppler de Pulso , Femenino , Humanos , Modelos Logísticos , Masculino , Persona de Mediana Edad , Infarto del Miocardio/diagnóstico por imagen , Infarto del Miocardio/fisiopatología , Estudios Prospectivos , Disfunción Ventricular Izquierda/diagnóstico por imagen , Disfunción Ventricular Izquierda/fisiopatologíaRESUMEN
Marfan's syndrome is an inherited connective tissue defect that affects many organs, especially of the musculoskeletal, ophthalmic and cardiovascular systems, and may be associated with some rare conditions. Here, we report the first known case of Marfan's syndrome, combined with situs inversus totalis with dextrocardia and discrete subaortic stenosis and aortic insufficiency in a 22-year-old woman.
Asunto(s)
Insuficiencia de la Válvula Aórtica/complicaciones , Insuficiencia de la Válvula Aórtica/diagnóstico por imagen , Dextrocardia/complicaciones , Dextrocardia/diagnóstico por imagen , Estenosis Subaórtica Fija/complicaciones , Estenosis Subaórtica Fija/diagnóstico por imagen , Ecocardiografía Transesofágica , Síndrome de Marfan/complicaciones , Síndrome de Marfan/diagnóstico por imagen , Situs Inversus/complicaciones , Situs Inversus/diagnóstico por imagen , Adulto , Ecocardiografía Doppler en Color , Electrocardiografía , Femenino , Humanos , RadiografíaRESUMEN
It is well known that the incidence of left ventricular (LV) thrombosis is high in patients with acute myocardial infarction (AMI). Due to the high degree of structural homology with plasminogen, lipoprotein(a) may produce thrombogenic effects by modulating the fibrinolytic system. However, the role of Lp(a) level in the formation of LV thrombus has not been studied. This study sought to determine whether Lp(a) is a risk factor for LV thrombus in patients with AMI. We have analyzed clinical, echocardiographic and biochemical data in 102 consecutive patients (aged 58+/-12 years, 92 men / 10 women) with first anterior AMI. Two-dimensional examination was performed on days 1, 3, 7, 15, and 30. Blood samples were obtained within 12 h after the onset of symptoms and before beginning the therapy. Plasma levels of fibrinogen and Lp(a) were measured using enzyme-linked immunosorbent assay and immunonephelometric methods, respectively. LV thrombus was detected in 20 (20.3%) patients. No significant difference was found for admission Lp(a) levels between patients with or without thrombus (30.5+/-17.2 vs 32.3+/-22.4 mg/dl, p = 0.7). Univariate analysis showed that patients with LV thrombus had a higher wall motion score index (1.8+/-0.3 vs 1.4+/-0.3, p = 0.002), a higher peak creatine kinase level (2945+/-898 vs 1805+/-1336, I / U p = 0.004), a larger end-diastolic volume (139.7+/-38.6 vs 114.1+/-41.8 ml, p = 0.04), a larger end-systolic volume (83.1+/-34.3 vs 59.2+/-30.6 ml, p = 0.02 ), and a lower ejection fraction (38+/-12 vs 47+/-11, p = 0.04). In multivariate analyses, only peak creatine kinase level (p = 0.04) and LV wall motion score index (p = 0.002) were independent predictors of left ventricular thrombus formation. These results suggest that Lp (a) is not a risk factor for LV thrombus in patients with AMI. Our data demonstrate that the best predictors of LV thrombus formation after AMI are a high peak creatine kinase level and a high LV wall motion score index.
Asunto(s)
Cardiopatías/sangre , Lipoproteína(a)/sangre , Infarto del Miocardio/complicaciones , Terapia Trombolítica , Trombosis/sangre , Anciano , Ecocardiografía , Femenino , Fibrinolíticos/administración & dosificación , Cardiopatías/tratamiento farmacológico , Cardiopatías/etiología , Ventrículos Cardíacos/diagnóstico por imagen , Heparina/administración & dosificación , Humanos , Hipertensión/complicaciones , Masculino , Persona de Mediana Edad , Factores de Riesgo , Sensibilidad y Especificidad , Fumar , Estreptoquinasa/administración & dosificación , Trombosis/tratamiento farmacológico , Trombosis/etiologíaRESUMEN
OBJECTIVE: The genetic defect of coagulation factor V, known as factor V Leiden, produces a resistance to degradation by activated protein C (APC) and increases the risk of venous thrombosis. However, the role of factor V Leiden in the formation of left ventricular (LV) thrombus has not been studied. We investigated whether factor V Leiden is a risk factor for LV thrombus in patients with acute myocardial infarction (AMI). METHODS AND RESULTS: We have analyzed clinical, echocardiographic and biochemical data in 135 consecutive patients (aged 58 +/- 13 years; 31 women) with first anterior AMI. Two-dimensional echocardiographic examination was performed on days 1, 3, 7, 15 and 30; LV thrombus was detected in 33 (24.4%) of 135 patients with AMI. The study also included 95 control subjects. Healthy age and sex-matched subjects without a personal or family history of ischaemic heart disease, stroke or thromboembolic disease served as a control group. Blood samples from the patients and controls were analyzed for the factor V Leiden mutation by DNA analysis, using the polymerase chain reaction. In addition, concentrations of fibrinogen, von Willebrand factor (vWF), tissue plasminogen activator (t-PA), plasminogen activator inhibitor-1 (PAI-1) and D-dimer were measured in 135 patients. There was no significant difference in the prevalence of factor V Leiden between patients and control subjects. The prevalence of the factor V mutation was 9% (3/33) in patients with thrombus, and 7.7% (8/103) in patients without thrombus. The prevalence of factor V Leiden was 7.3% (7/95) in control subjects. No significant differences in plasma fibrinogen (480 +/- 195 vs. 444 +/- 179 mg/dl, p = 0.6), D-dimer (471 +/- 256 vs. 497 +/- 293 ng/dl, p = 0.7), vWF (112 +/- 18 vs. 103 +/- 15%, p=0.5), PAI-1 (26.7+/- 9.8 vs. 28.1 +/- 10.2 ng/dl, p = 0.6), and t-PA (19.8 +/- 8.7 vs. 17.2 +/- 9.1 ng/dl, p = 0.7), levels are found in patients with LV thrombus when compared with those without LV thrombus. Multivariate analyses showed that peak creatine kinase level (p = 0.002) and LV wall motion score index (p = 0.003) were independent predictors of LV thrombus formation. CONCLUSION: Factor V Leiden mutation is not a risk factor for LV thrombus formation in patients with AMI.
Asunto(s)
Factor V/fisiología , Cardiopatías/etiología , Infarto del Miocardio/complicaciones , Trombosis/etiología , Análisis de Varianza , Estudios de Casos y Controles , Distribución de Chi-Cuadrado , Factor V/genética , Femenino , Cardiopatías/sangre , Cardiopatías/genética , Ventrículos Cardíacos , Humanos , Modelos Logísticos , Masculino , Persona de Mediana Edad , Mutación , Infarto del Miocardio/sangre , Estudios Prospectivos , Factores de Riesgo , Trombosis/sangre , Trombosis/genéticaRESUMEN
Coronary artery aneurysm (CAA) is a relatively rare disease that may cause angina, myocardial infarction, sudden death due to thrombosis, embolisation, or rupture. This report describes the case of a man aged 65 years old who had an anterior myocardial infarction due to left anterior descending artery (LAD) aneurysm. We attempted early percutaneous transluminal coronary angioplasty (PTCA) for treatment of acute myocardial infarction, but were not successful. He was then treated with intracoronary streptokinase. Serial coronary angiographies showed recanalisation and aneurysm on the LAD. The patient was operated on with coronary bypass surgery, and treated with an oral anticoagulant, nitrate, and blocker. He was well after one year of follow-up.
Asunto(s)
Aneurisma Coronario/complicaciones , Infarto del Miocardio/etiología , Anciano , Angioplastia Coronaria con Balón , Aneurisma Coronario/diagnóstico por imagen , Aneurisma Coronario/cirugía , Angiografía Coronaria , Puente de Arteria Coronaria , Humanos , Masculino , Infarto del Miocardio/terapia , Terapia TrombolíticaRESUMEN
Behçet's disease is recognised as a chronic multisystem disorder with vasculitis as its underlying pathological process. Cardiac involvement is rare and often associated with poor prognosis. A case of a 33 year old man with Behçet's disease, presenting with a large right ventricle and right atrial thrombus, is reported. Two dimensional (cross sectional), colour Doppler, and transoesophageal echocardiography, angiography, computed tomography, and magnetic resonance imaging were used to diagnose the disease. With cyclophosphamide and dexamethasone treatment, the cardiac lesions progressively resolved.
Asunto(s)
Síndrome de Behçet/complicaciones , Cardiopatías/complicaciones , Trombosis/complicaciones , Adulto , Antiinflamatorios/uso terapéutico , Anticoagulantes/uso terapéutico , Síndrome de Behçet/diagnóstico , Síndrome de Behçet/tratamiento farmacológico , Colchicina/uso terapéutico , Ciclofosfamida/uso terapéutico , Dexametasona/uso terapéutico , Quimioterapia Combinada , Ecocardiografía Doppler en Color , Ecocardiografía Transesofágica , Atrios Cardíacos/diagnóstico por imagen , Cardiopatías/diagnóstico , Cardiopatías/tratamiento farmacológico , Ventrículos Cardíacos/diagnóstico por imagen , Humanos , Inmunosupresores/uso terapéutico , Masculino , Trombosis/diagnóstico , Trombosis/tratamiento farmacológico , Warfarina/uso terapéuticoRESUMEN
OBJECTIVE: Factor V Leiden mutation, the genetic defect underlying resistance to activated protein C, is the most common risk factor for venous thrombosis. Factor V Leiden mutation and its relation to post-myocardial infarction (MI) complications including angina pectoris, heart failure, reinfarction and cardiac mortality has not been investigated. We aimed to investigate this relation. METHODS: The prevalence of factor V Leiden mutation was investigated in 122 patients with first acute myocardial infarction (aged 56 +/- 11, 82 men/40 women). These patients were divided into two groups according to whether the patients had factor V Leiden mutation (Group I) or not (Group II). Post MI complications were evaluated during 18 months. Blood samples from the patients were analyzed for factor V Leiden mutation by DNA analysis, using the polymerase chain reaction (PCR). RESULTS: Factor V Leiden was detected in 11 (9%) patients (aged; 54 +/- 10, 5 women/men) and was not detected in 111(90%) patients (aged; 56 +/- 11; 35 women/76 men) of the 122 patients. There were no significant differences between Group I and Group II in terms of post MI complications, including reinfarction (27% vs. 29%; p > 0.05, respectively), angina pectoris (45% vs. 38%; p > 0.05, respectively), heart failure (27% vs. 23%; p > 0.05, respectively) and cardiac mortality (18% vs. 14%; p > 0.05, respectively). CONCLUSION: Post MI complications, including reinfarction, heart failure, angina pectoris and cardiac mortality were not increased in patients with factor V Leiden.
Asunto(s)
Factor V/genética , Infarto del Miocardio/genética , Infarto del Miocardio/mortalidad , Resistencia a la Proteína C Activada/genética , Femenino , Humanos , Masculino , Persona de Mediana Edad , Infarto del Miocardio/complicaciones , Mutación Puntual , Reacción en Cadena de la Polimerasa , Prevalencia , Pronóstico , Factores de Riesgo , Turquía/epidemiologíaRESUMEN
PURPOSE: The purpose of this study was to evaluate the safety and efficacy of sonographically guided percutaneous drainage and irrigation of hepatic hydatid cysts. METHODS: Sixty-one patients with 84 hepatic hydatid cysts were treated using the puncture, aspiration, injection, and reaspiration (PAIR) technique under sonographic guidance. Patients with cysts larger than 6 cm in diameter underwent PAIR followed by percutaneous drainage (PAIR-PD). The cysts were sterilized by the injection of 1 of 2 scolicidal agents, 20% hypertonic saline solution (38 patients) or 0.5% silver nitrate (23 patients). All patients underwent follow-up examinations for 1 month-6 years after aspiration. Clinical and radiologic examinations and laboratory analyses were performed every month for the first 6 months and then at 3-month intervals. RESULTS: Serial sonographic examinations revealed a heterogeneous echo pattern in 78 cysts (93%); a progressive decrease in diameter in 76 cysts (90%); calcification of the cyst wall, cystic contents, or both in 10 cysts (12%); and complete disappearance of 1 cyst (1%) in a patient who had been monitored for over 6 years. Five patients developed urticaria, and 6 developed fever. One patient developed a biliary fistula after the first aspiration attempt. Two patients developed infection of the cyst cavity after PAIR-PD and were successfully treated with oral antibiotics. An anaphylactic reaction developed in 2 patients and was successfully treated with antiallergenic medication. No recurrence of hydatid disease after PAIR or PAIR-PD was observed in any patient over the follow-up period of 72 months (mean, 26 +/- 27 months). CONCLUSIONS: Percutaneous drainage of hydatid cysts is a safe, effective, and reliable treatment. Antiallergenic medication is required before PAIR or PAIR-PD. Both sclerosing agents, hypertonic saline and silver nitrate solutions, gave excellent results.
Asunto(s)
Equinococosis Hepática/terapia , Ultrasonografía Intervencional , Adolescente , Adulto , Anciano , Anafilaxia/inducido químicamente , Antialérgicos/uso terapéutico , Anticestodos/administración & dosificación , Anticestodos/efectos adversos , Anticestodos/uso terapéutico , Fístula Biliar/etiología , Niño , Difenhidramina/uso terapéutico , Drenaje/efectos adversos , Equinococosis Hepática/diagnóstico por imagen , Femenino , Fiebre/inducido químicamente , Estudios de Seguimiento , Humanos , Estudios Longitudinales , Masculino , Persona de Mediana Edad , Punciones/efectos adversos , Solución Salina Hipertónica/administración & dosificación , Solución Salina Hipertónica/efectos adversos , Solución Salina Hipertónica/uso terapéutico , Soluciones Esclerosantes/administración & dosificación , Soluciones Esclerosantes/efectos adversos , Soluciones Esclerosantes/uso terapéutico , Nitrato de Plata/administración & dosificación , Nitrato de Plata/efectos adversos , Nitrato de Plata/uso terapéutico , Succión , Irrigación Terapéutica , Urticaria/inducido químicamenteRESUMEN
BACKGROUND: The relation between left ventricular (LV) diastolic function and LV thrombus has not yet been fully investigated. The aim of this study was to determine whether early assessment of Doppler-derived mitral deceleration time (DT), a measure of LV compliance and filling, may predict LV thrombus formation after acute myocardial infarction. METHODS AND RESULTS: Two-dimensional and Doppler echocardiographic examinations were performed in 98 consecutive patients (aged 57 +/- 12 years; 8 women) with first acute myocardial infarction. The patients were studied within 24 hours and at days 3, 7, 15, and 30 after arrival to the coronary care unit. Mitral flow velocities were obtained from the apical 4-chamber view with pulsed Doppler. LV thrombus was detected in 20 of 98 patients. Patients were divided into 2 groups according to LV thrombus formation: group 1 (n = 20) with thrombus and group 2 (n = 78) without thrombus. Mitral E-wave DT was significantly shorter in group 1 than group 2 (134 ms vs 175 ms; P <.001). Patients in group 1 had significantly larger LV end-diastolic and end-systolic volumes and a higher wall motion score index than patients in group 2 (133 +/- 39 mL vs 112 +/- 41 mL, P =.03; 83 +/- 34 mL vs 59 +/- 30 mL, P =.003; and 1.8 +/- 0.3 mL vs 1.5 +/- 0.3 mL, P =.007, respectively). The LV ejection fraction was significantly lower in group 1 than in group 2 (39% +/- 13% vs 48% +/- 12%; P =.004). In a multivariate regression analysis, mitral E-wave DT was identified as an independent variable related to development of LV thrombus (P =.04). CONCLUSIONS: Doppler-derived mitral DT is superior to conventional clinical and 2-dimensional echocardiographic assessment in estimating the risk of left ventricular thrombosis after myocardial infarction.
Asunto(s)
Ecocardiografía Doppler , Válvula Mitral/fisiopatología , Infarto del Miocardio/fisiopatología , Trombosis/etiología , Disfunción Ventricular Izquierda/etiología , Anciano , Velocidad del Flujo Sanguíneo , Femenino , Cardiopatías/etiología , Humanos , Masculino , Persona de Mediana Edad , Válvula Mitral/diagnóstico por imagen , Infarto del Miocardio/complicaciones , Infarto del Miocardio/diagnóstico por imagen , Valor Predictivo de las Pruebas , Pronóstico , Factores de Riesgo , Trombosis/diagnóstico por imagen , Trombosis/fisiopatología , Factores de Tiempo , Disfunción Ventricular Izquierda/diagnóstico por imagenRESUMEN
A Gerbode defect is a ventricular septal defect that communicates directly between the left ventricle and the right atrium. The pathology may be due to a congenital defect, can result from trauma, or can occur after endocarditis or aortic valve replacement. We report the case of a 20-year-old man who has a defect between the left ventricle and the right atrium (Gerbode defect) that was diagnosed with two-dimensional color Doppler echocardiography.
Asunto(s)
Ecocardiografía Doppler en Color , Defectos de los Tabiques Cardíacos/diagnóstico por imagen , Adulto , Humanos , MasculinoRESUMEN
We report a 16-year-old girl with acute rupture of the sinus of Valsalva. This case is unique in that the right coronary sinus of Valsalva ruptured into both the right and left ventricles, producing severe aortic insufficiency. The diagnosis was made with two-dimensional and color Doppler echocardiography which showed an abnormal jet flow from the aortic root into both ventricles. The diagnosis was confirmed by magnetic resonance imaging and aortic root angiography. Early diagnosis is important so that urgent surgical treatment can be taken.